Drug Discovery of COPD
Chronic obstructive pulmonary disease is an expanding worldwide medical issue and cause of death. COPD mostly influencing small airway routes and lung parenchyma that prompts dynamic aviation route deterrent. COPD is a standout amongst the most widely recognized infections on the globe, and there is a global increase in generality, however there are no drugs available at present that halt the relentless progression of this disease. In any case, a superior perception of the cell and molecular mechanisms that are associated with the underlying inflammatory and destructive processes has uncovered a few new centres for which drugs are presently being developed, and the prospects for detection new medications are good.
Related Conference of Drug Discovery of COPD
14th International Conference on COPD Clinical Trials & Lung Care Advances
6th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Pulmonary & Respiratory Medicine
Drug Discovery of COPD Conference Speakers
Recommended Sessions
- Asthma and Allergy
- Cardio Pulmonary Disorders
- Chronic bronchitis
- Chronic obstructive pulmonary disease
- COPD and Air Pollution
- COPD Pathogenesis
- COPD-Chronic obstructive pulmonary disease
- Depression and Anxiety in COPD
- Diagnosis and Treatment of COPD
- Drug Discovery of COPD
- Effect of COVID-19 on Lungs
- Emphysema
- Lung cancer
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Transplantation
- Pediatric Neonatal Care in COPD
- Pediatric Pulmonology & Critical care
- Prevention of COPD
- Pulmonary diseases
- Pulmonary Rehabilitation
- Respiratory and sleep Medicine
- Respiratory Tract Infections
- Self-Management and Prevention of COPD
- Spirometry
- Stages & Severity on Lung Diseases
- Tobacco control
- Types of COPD
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
